SERPINA1 and chronic obstructive pulmonary disease: Augmentation therapy using purified α1-antitrypsin (A1AT), such as human plasma-pooled Prolastin®, has been used clinically for the treatment of chronic obstructive pulmonary disease (COPD)39.